These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 6927732)
1. Kidney function after improved metabolic control in newly diagnosed diabetes and in diabetic patients with nephropathy. Ciavarella A; Flammini M; Stefoni S; Borgnino LC; Forlani G; Bacci L; Vannini P Diabetes Care; 1982; 5(6):624-9. PubMed ID: 6927732 [TBL] [Abstract][Full Text] [Related]
2. Effect of long-term near-normoglycemia on the progression of diabetic nephropathy. Ciavarella A; Vannini P; Flammini M; Bacci L; Forlani G; Borgnino LC Diabete Metab; 1985 Feb; 11(1):3-8. PubMed ID: 3884404 [TBL] [Abstract][Full Text] [Related]
3. Tubular dysfunction in the early stage of diabetic nephropathy. Tanaka A; Shima K; Fukuda M; Tahara Y; Yamamoto Y; Kumahara Y Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397 [TBL] [Abstract][Full Text] [Related]
4. Long term correction of hyperglycaemia and progression of renal failure in insulin dependent diabetes. Viberti GC; Bilous RW; Mackintosh D; Bending JJ; Keen H Br Med J (Clin Res Ed); 1983 Feb; 286(6365):598-602. PubMed ID: 6402163 [TBL] [Abstract][Full Text] [Related]
5. Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycemia. Viberti GC; Mackintosh D; Bilous RW; Pickup JC; Keen H Kidney Int; 1982 May; 21(5):714-20. PubMed ID: 7050509 [TBL] [Abstract][Full Text] [Related]
6. Nephelometry in the clinical assessment of glomerular proteinuria and tubular function in diabetic nephropathy. Solerte SB; Severgnini S; Locatelli M; Cerutti N; Rondanelli M; Netti MA; Ferrari E; Fioravanti M Clin Nephrol; 1997 Sep; 48(3):151-8. PubMed ID: 9342486 [TBL] [Abstract][Full Text] [Related]
7. Effects of short-term strict metabolic control on kidney function and extracellular fluid volume in incipient diabetic nephropathy. Mathiesen ER; Gall MA; Hommel E; Skøtt P; Parving HH Diabet Med; 1989; 6(7):595-600. PubMed ID: 2527700 [TBL] [Abstract][Full Text] [Related]
8. Factors affecting the urinary excretion of albumin in insulin-dependent diabetes. Whiteside C; Zinman B; Zuniga-Guajardo S; Silverman M Clin Invest Med; 1987 Jul; 10(4):282-9. PubMed ID: 2443293 [TBL] [Abstract][Full Text] [Related]
9. Determination of urinary lysozyme for potential detection of tubular dysfunction in diabetic nephropathy. Shima K; Hirota M; Fukuda M; Tanaka A Clin Chem; 1986 Oct; 32(10):1818-22. PubMed ID: 3530528 [TBL] [Abstract][Full Text] [Related]
10. Kidney function during 12 months of strict metabolic control in insulin-dependent diabetic patients with incipient nephropathy. Feldt-Rasmussen B; Mathiesen ER; Hegedüs L; Deckert T N Engl J Med; 1986 Mar; 314(11):665-70. PubMed ID: 3513009 [TBL] [Abstract][Full Text] [Related]
11. The effect of continuous subcutaneous insulin infusion on renal function in type I diabetic patients with and without proteinuria. van Ballegooie E; de Jong PE; Donker AJ; Sluiter WJ Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():722-4. PubMed ID: 3991567 [TBL] [Abstract][Full Text] [Related]
12. [Diagnostic significance of urinary immunoglobulin G in diabetic nephropathy]. Yashima I; Hirayama T; Shiiki H; Kanauchi M; Dohi K Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):787-96. PubMed ID: 10655727 [TBL] [Abstract][Full Text] [Related]
13. The effect of bromhexine on albumin excretion in insulin dependent diabetes. Marshall SM; Shearing PA; Shelley JH; Alberti KG Diabete Metab; 1991; 17(3):332-6. PubMed ID: 1884876 [TBL] [Abstract][Full Text] [Related]
14. Effect of control of blood glucose on urinary excretion of albumin and beta2 microglobulin in insulin-dependent diabetes. Viberti GC; Pickup JC; Jarrett RJ; Keen H N Engl J Med; 1979 Mar; 300(12):638-41. PubMed ID: 84336 [TBL] [Abstract][Full Text] [Related]
15. Diurnal variation in urinary protein excretion in diabetic nephropathy. Stehouwer CD; Fischer HR; Hackeng WH; den Ottolander GJ; Donker AJ Nephrol Dial Transplant; 1991; 6(4):238-43. PubMed ID: 1881577 [TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of plasma proteins in diabetic subjects. Increased excretion of kappa light chains in diabetic patients with and without proliferative retinopathy. Teppo AM; Groop L Diabetes; 1985 Jun; 34(6):589-94. PubMed ID: 3924692 [TBL] [Abstract][Full Text] [Related]
17. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy. Katavetin P; Eiam-Ong S; Suwanwalaikorn S J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002 [TBL] [Abstract][Full Text] [Related]
18. Artificial endocrine pancreas and diabetic nephropathy. Vannini P; Ciavarella A; Flammini M; Stefoni S; Bacci L; Borgnino LC Life Support Syst; 1983; 1 Suppl 1():41-4. PubMed ID: 6336454 [No Abstract] [Full Text] [Related]